Clinical research network for nemaline myopathy
Part of Bones, joints & muscles, Brain & nervous system, Genetic & congenital clinical trials.
This study creates a network to gather information about people with nemaline myopathy, a genetic muscle disorder. It aims to improve understanding and support for future research and care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 0 and 18 years old
- You have a confirmed diagnosis of nemaline myopathy through genetic testing (changes in the ACTA1 or NEB genes)
- You or your parent/guardian can sign a consent form to join
- You do not have any other serious medical conditions that would interfere with the study
- You are not currently in another trial that tests a treatment
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tracks the health of people with nemaline myopathy over time to learn more about how the condition progresses. By joining, you help researchers understand the disease better, which may support future care and treatment development.
This study follows people with nemaline myopathy over time to better understand how the disease progresses. It helps researchers learn more about the condition and plan future treatments.
This study follows patients with congenital myopathies to understand how their muscles get tired over time. It may help develop better treatments.
This research study looks at genes and molecules to better understand congenital myopathies (birth-related muscle weakness). It may help explain the cause of symptoms and improve future diagnoses for you and your family.
This study follows people with a rare genetic muscle condition called TNNT1 myopathy over time. Researchers will track how the disease progresses to better understand it and help plan future treatments.
This trial is building a biobank (a secure research collection) from people with neuromuscular diseases, their families, or healthy volunteers. By joining, you help researchers study these conditions and improve future treatments.
Hear when a new Nemaline Myopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.